Wolverine (BPC-157 + TB-500 10/10MG)
$72.00
Research-grade Wolverine Blend (BPC-157 10 mg + TB-500 10 mg) is a widely investigated dual-peptide combination studied for angiogenesis signaling, cytoskeletal dynamics, collagen deposition pathway characterization, gastrointestinal mucosal pathway research, inflammation modulation, and multi-tissue remodeling in controlled laboratory and preclinical model settings. For Research Use Only. Not for human use.
72 Athena Points with this purchaseIn stock
Overview
Wolverine Blend combines two of the most researched peptides in regenerative biology into a single research formulation for controlled laboratory studies. By pairing BPC-157 with TB-500, this blend has become a popular choice for researchers investigating tissue repair, recovery pathways, and cellular regeneration. These peptides are frequently studied together because they target complementary biological processes involved in muscle, tendon, ligament, and connective tissue research. As a result, Wolverine is widely used in studies focused on recovery, mobility, and overall tissue health.
Common Areas of Research:
• Muscle Recovery & Repair
• Tendon & Ligament Healing
• Connective Tissue Regeneration
• Joint & Mobility Research
• Cellular Recovery & Regenerative Biology
KEY CHARACTERISTICS
BPC-157 10MG (Body Protection Compound-157)
TB-500 10MG (Thymosin Beta-4 fragment 17-23, Ac-LKKTETQ)
A 7-amino-acid actin-sequestering peptide studied for its roles in cell migration, angiogenesis signaling, and inflammatory pathway modulation in laboratory models
Together, BPC-157 and TB-500 are frequently investigated for complementary and potentially synergistic activity across tissue repair signaling pathways, making the Wolverine Blend a commonly requested dual-peptide combination in musculoskeletal, gastrointestinal, and neurovascular research contexts.
Analytical Specifications
- High-purity BPC-157 (≥ 98%) + TB-500 (≥ 98%) verified by HPLC/MS
- 1:1 ratio (10 mg BPC-157 + 10 mg TB-500 per vial) – a commonly studied blend ratio in peer-reviewed literature
- Lyophilized dual-peptide blend for long-term stability under appropriate storage conditions
- Full Certificate of Analysis (COA) available for each component and blend verification
- Manufactured in GMP-aligned, ISO-compliant facilities
- BPC-157: Investigated in preclinical models for NO/VEGF pathway modulation, extracellular matrix signaling, and gastrointestinal mucosal pathway research
- TB-500: Studied actin polymerization dynamics, endothelial cell migration pathways, angiogenesis signaling, and VEGF upregulation in laboratory models
- Combined investigation: Studied for collagen deposition signaling, wound closure pathway characterization, and multi-tissue remodeling models in preclinical settings.
Research Focus Areas (Based on scientific literature; not intended as therapeutic claims. For Research Use Only.)
Why Researchers Select This Blend
- Frequently requested dual-peptide research combination with a documented 10 mg + 10 mg ratio in peer-reviewed studies
- Transparent analytical data (HPLC >98%, MS sequence confirmation for both peptides)
- Suitable for laboratory use in orthopedic, gastroenterology, and regenerative pathway research models
- Competitive research pricing with bulk options available
Related products
